We are thrilled to announce that ANS Biotech will be participating in BIO-Europe 2024, one of the leading biotechnology events in Europe. This year’s edition will take place in Stockholm from November 4-6, 2024.
BIO-Europe is a crucial gathering for professionals across the life sciences sector, where key industry players come together to foster collaborations, discuss the latest advancements, and explore new business opportunities.
Our team will be represented by Yassine Darbaky (CBO), who will be actively engaging with partners and exploring innovative solutions within the field of preclinical pain pharmacology.
At ANS Biotech, we specialize in providing cutting-edge preclinical research services focused on pain models. During the event, Yassine will also take the opportunity to present the latest version of our ALGOGram™ screening tool. This upgraded version offers even more robust capabilities for evaluating novel compounds in preclinical pain models, providing our partners with tailored solutions for their drug development projects.
BIO-Europe is well-known for its role in driving partnerships that shape the future of biotechnology. The event attracts over 4,000 participants from more than 60 countries, with thousands of one-on-one partnering meetings taking place during the three days. This makes it the ideal venue to discuss new project collaborations and expand our global network.
👉 Interested in connecting with us?
If you would like to schedule a meeting during BIO-Europe, please don’t hesitate to reach out to Yassine Darbaky. We are eager to discuss how we can support your preclinical development projects and introduce you to the enhanced capabilities of ALGOGram™.
We look forward to seeing you in Stockholm for BIO-Europe 2024!
A heartfelt thank you to the Auvergne-Rhône-Alpes region for their support, which made our participation in this key event possible. ✨
